NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Turbine

Turbine

Private
London, EnglandHealthcare & Life Scienceshttps://www.turbine.ai

Last Round

Series B

Feb 24, 2026

Total Funding Raised

$71.22M

Company Overview

Turbine (Drug Discovery) is a biotechnology company that develops cancer combination therapies aimed at elucidating disease biology and creating personalized treatment plans through advanced bioinformatics and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Infrastructure

Keywords

AI drug discoverycell simulationoncology drug discoverybiological simulationcancer digital twinin-silico drug discoverybiotech AItarget discoverypreclinical drug discoverybiomarker discoveryvirtual lab platformbiopharma partnershipsinterpretable AIwet lab validationADC discoverycombination therapy design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Turbine Comparables

Compare Turbine with similar companies based on industry and business-model similarity.

Turbine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CytoReason
84%
Aitia
81%
DeepLife
79%

Turbine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 24, 2026
Series AApr 4, 2025
Series A ExtensionMay 16, 2024
Series AJun 20, 2023
Series ANov 22, 2022
Seed
Jan 7, 2021

Key People

Founding team and executive leadership

Daniel Veres

Chief Scientific Officer, Co-Founder

Founding Team

Kristóf Szalay

CTO & Founder

Founding Team

Szabolcs Nagy

CEO, Co-founder

Founding Team

Mate Zsombok

Chief Financial Officer

Executive Team

Turbine Investors

Notable investors and investment history

Turbine investors
InvestorRounds
B Capital GroupSeries A
Interactive Venture PartnersSeries B
Day One CapitalSeries A
o2h venturesSeries A, Seed
Accenture VenturesSeries A Extension
Fin Venture CapitalSeries A
TTV CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 4, 2025

    Will simulate hard-to-treat cancer patient populations.

  • Jul 10, 2025

    Gregory Vladimer appointed to Scientific Advisory Board.

Turbine Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Turbine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Turbine's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range116
Year Founded2016
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.